• FDA OKs Horizon Pharma, Inc.'s Time-release Painkiller More...

• EU Approves Vertex Pharmaceuticals Incorporated (VRTX)'s KALYDECO for Cystic Fibrosis More...

• EU OK for Almirall's COPD Drug Eklira Genuair More...

• Eisai Inc. (ESALF.PK) Gets Approval for Anti-seizure Drug More...

• Genentech (RHHBY)'s Lucentis Backed by FDA Panel for Diabetic Blindness More...

• Sucampo Pharmaceuticals, Inc. and Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Announce Filing of Supplemental New Drug Application for AMITIZA (Lubiprostone) in Opioid-induced Constipation More...

• Alimera Sciences (ALIM)' ILUVIEN&#0174 Receives Marketing Authorization in Germany for the Treatment of Chronic Diabetic Macular Edema More...

• Ariad Pharmaceuticals, Inc. (ARIA) Announces Initiation of Randomized Phase 3 Trial of Ponatinib in Newly Diagnosed Patients with Chronic Myeloid Leukemia More...

• SuppreMol Begins Development of Anti-IL-3 Monoclonal Antibody to Diagnose and Treat Early Stage Rheumatoid Arthritis More...

• ViroPharma Incorporated (VPHM)'s Cinryze&#0174 (C1 esterase inhibitor [human]) Open Label Prophylaxis Study Showed Up to 2.6 Years of Effectiveness in Majority of Subjects With Hereditary Angioedema More...

• Alcohol Can Triple Original Dose of Medicine, Monash University Reveals More...

• Late Shift Linked to Heart Risk, Western University Study More...

• Yoga May Help Stroke Survivors Improve Balance, Indiana University Study More...

• Scientists Reveal New Clues to Alzheimer's Risk Gene, University of Southampton Study More...

• The Longer You're Awake, the Slower You Get, Brigham and Women's Hospital Study More...

• Neurotez, Inc. Announces Grant of U.S. Patent 8,227,408 Around Its Leptin Therapy for Alzheimer's Disease More...

• NeuralStem Inc. Receives Notice of Issuance for Patent Covering Human Neural Cell Transplantation for Neurodegenerative Conditions More...

• Mylan Inc. (MYL) Launches Generic Version of Sporanox&#0174 Capsules More...

• Will Biogen Idec, Inc. (Massachusetts) (BIIB) Fall for Elan Corporation PLC (ELN)'s Buyout Bait More...

• Exclusive: Human Genome Sciences, Inc. (HGSI) Rejected Amgen (AMGN)'s $7 Billion Bid in 2010 More...

• Novogen Limited (NVGN) Announces Merger Agreement With Kai Medicaland Distribution of MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) (MSHL) Shares More...

• NSF International Acquires Becker & Associates Consulting, Inc., a Leading Clinical, Regulatory and Scientific Consulting Firm Specializing in the FDA-Regulated Medical Devices, Pharmaceuticals and Biologics Industries More...

• Position of Merck Serono Concerning the Recommendation Made by CRCT of Geneva More...

• Teva Pharmaceutical Industries Limited (TEVA), Procter & Gamble (PG) to Build Indian Plant for $89 Million More...

• BioCon Limited (BIOCON.NS) Close to Oral Insulin Deal With Bristol-Myers Squibb Company (BMY) More...

• Roche (RHHBY) and AREVA Med LLC Join Forces in the Fight Against Cancer and Create a Novel Radio-Immunotherapy More...

• Gentris Corporation Announces Collaboration to Study Blood Stability More...

• Metabolix, Inc. Signs Letter of Intent With Antibióticos for Production of Mirel Biopolymer Resin More...

• Endocyte, Inc. (ECYT) Appoints David Meek to Newly Created Position of Chief Commercial Officer More...

• Durata Therapeutics, Inc. Adds Independent Director Lisa M. Giles to the Company's Board More...

• Roche (RHHBY) Restructuring Causes $1.7 Billion Charge More...

• Curis, Inc. (CRIS) to Release Second Quarter 2012 Financial Results and Hold Conference Call on August 2, 2012 More...

• Codexis, Inc. (CDXS) to Announce Second Quarter 2012 Financial Results on August 9, 2012 More...

• Gilead Sciences, Inc. (GILD) Announces Second Quarter 2012 Financial Results More...

• McKesson Corporation Reports Fiscal 2013 First-Quarter Results More...

• GlaxoSmithKline (GSK) Admits "Mistakes" Over US Guilt More...